The year 2025 has marked a troubling resurgence of measles in the United States, with 1,288 confirmed cases reported as of July 9, 2025, the highest since 1992. This highly contagious, vaccine-preventable disease has re-emerged due to declining vaccination rates, disruptions from the COVID-19 pandemic, and imported cases from global travel. For public health officials, hospital epidemiologists, and infection prevention teams, understanding the causes and implementing robust infection control strategies are critical to curbing this outbreak and preventing further spread. This article explores the current measles situation, its impacts, and actionable strategies to strengthen infection control, with a focus on vaccination and outbreak response.
Understanding the Measles Resurgence
Current Statistics and Trends
The measles resurgence in 2025 has reached alarming levels, with key data highlighting the scope of the issue:
- Total Cases: 1,288 confirmed cases across 39 jurisdictions, including states like Texas, New Mexico, and New York.
- Outbreaks: 27 outbreaks, with 88% of cases (1,130) linked to these clusters.
- Texas Outbreak: The largest outbreak, with 753 cases since late January 2025, primarily in West Texas.
- Fatalities: Three deaths reported, including two school-aged children in Texas and one in New Mexico.
These figures, reported by the Centers for Disease Control and Prevention (CDC), indicate a significant public health challenge, surpassing the 2019 outbreak of 1,274 cases.
Causes of the Resurgence
Several factors have contributed to the 2025 measles resurgence:
- Declining Vaccination Rates: MMR vaccination coverage has fallen below the 95% threshold needed for herd immunity in many U.S. jurisdictions.
- Global Measles Surge: The COVID-19 pandemic disrupted routine vaccination services worldwide, leading to a global increase in measles cases and a higher risk of imported cases.
- Low Vaccination in Specific Communities: Outbreaks are concentrated in close-knit communities with low vaccination coverage, such as those in New Mexico, Oklahoma, and Texas, where 82% of 800 cases in early 2025 were outbreak-related.
- International Travel: Frequent travel among similar communities across states and countries facilitates rapid measles spread, with 48 imported cases reported, 92% among U.S. residents returning from travel.
- High Proportion of Unvaccinated Cases: 96% of cases (771) occurred in unvaccinated individuals or those with unknown vaccination status, with 77% unvaccinated when excluding Texas cases.
These factors underscore the need for targeted interventions to address both local and global challenges.
Impact of Measles
Health Impacts
Measles is a highly contagious viral disease that can lead to severe complications, particularly in unvaccinated individuals:
- Complications: Pneumonia, encephalitis, and secondary infections like ear infections are common. Post-infectious encephalitis occurs in about one in every 1,000 cases.
- Hospitalizations: In 2025, 11% of measles patients (approximately 142) have been hospitalized.
- Fatalities: Three deaths have been reported, highlighting the disease’s potential severity, especially in children and immunocompromised individuals.
The majority of cases (96%) involve unvaccinated individuals, emphasizing the critical role of vaccination in preventing severe outcomes.
Societal Impacts
Beyond health consequences, measles outbreaks have broader societal effects:
- School Closures: Outbreaks often lead to school closures, disrupting education and community activities.
- Economic Costs: Healthcare expenses, lost productivity, and public health response efforts place a significant economic burden on affected communities.
- Public Health Strain: Outbreaks require extensive resources for contact tracing, quarantine, and vaccination campaigns, straining public health systems.
These impacts highlight the urgency of effective infection control measures to mitigate both health and societal consequences.
Infection Control Strategies
Vaccination as Primary Prevention
Vaccination remains the cornerstone of measles prevention:
- Two-Dose MMR Schedule: The CDC recommends two doses of the measles, mumps, and rubella (MMR) vaccine, with the first dose at 12–15 months and the second at 4–6 years. This provides 97% protection against measles.
- Catch-Up Vaccination: Implement programs to vaccinate under-vaccinated populations, including adults without evidence of immunity.
- Community Engagement: Address vaccine hesitancy through education campaigns that highlight the safety and efficacy of the MMR vaccine.
For more information on vaccination schedules, visit the CDC’s Measles Vaccination page.
Outbreak Response
Effective outbreak response is critical to containing measles spread:
- Rapid Identification and Isolation: Suspected cases should be identified and isolated immediately, using airborne infection isolation rooms (AIIRs) or private rooms if AIIRs are unavailable.
- Contact Tracing and Quarantine: Trace contacts of confirmed cases and quarantine exposed individuals for 21 days (or 28 days if immunoglobulin is used).
- Mass Vaccination Campaigns: Conduct targeted vaccination campaigns in affected areas to halt transmission, as seen in the Texas outbreak response.
The Center for Outbreak Response Innovation (CORI) provides tools like the epiENGAGE Measles Outbreak Simulator to help public health officials model and manage outbreaks.
Healthcare Settings
In healthcare settings, strict infection control measures are essential to prevent nosocomial transmission:
- Ensure HCP Immunity: All healthcare personnel (HCP) must have presumptive evidence of immunity, such as two MMR doses, laboratory evidence of immunity, or birth before 1957. During outbreaks, unvaccinated HCP should receive two MMR doses.
- Standard and Airborne Precautions: Use N95 respirators for HCP and place patients in AIIRs with at least 6–12 air changes per hour. If unavailable, use private rooms with closed doors and mask patients.
- Patient Management: Minimize patient transport, use facemasks during transport, and limit visitors to those with confirmed immunity.
- Environmental Control: Use EPA-registered disinfectants for cleaning and manage PPE as regulated medical waste.
- Manage Exposed Individuals: Monitor exposed HCP and patients for 21–28 days, depending on postexposure prophylaxis, and place exposed patients on Airborne Precautions from day 5 to 21 post-exposure.
For detailed guidelines, refer to the CDC’s Interim Infection Prevention and Control Recommendations for Measles.
| Infection Control Measures | Description | Key Considerations |
| HCP Immunity | Ensure two MMR doses or lab evidence of immunity | Critical during outbreaks |
| Isolation | Use AIIRs or private rooms for suspected cases | Minimize shared air space |
| Airborne Precautions | N95 respirators for HCP, proper ventilation | Maintain for 4 days post-rash onset |
| Environmental Control | EPA-registered disinfectants, PPE disposal | Standard cleaning protocols |
Strengthening Vaccination Efforts
Importance of Herd Immunity
Herd immunity requires at least 95% vaccination coverage to prevent measles outbreaks. Low vaccination rates in specific communities create pockets of susceptibility, as seen in the Texas outbreak, where 82% of cases were linked to under-vaccinated groups. Maintaining high coverage is essential to protect vulnerable populations, such as infants too young to be vaccinated and immunocompromised individuals.
Strategies to Increase Vaccination Rates
To boost vaccination coverage, public health officials can implement the following strategies:
- Education and Awareness: Provide clear, evidence-based information about the MMR vaccine’s safety and efficacy to counter misinformation.
- Community Engagement: Partner with community leaders, religious groups, and trusted messengers to promote vaccination in hesitant populations.
- Convenience: Offer vaccines at accessible locations like schools, clinics, and mobile units to reduce barriers.
- Mandatory Vaccination Policies: Consider policies requiring MMR vaccination for school entry or healthcare employment, where legally feasible.
The World Health Organization (WHO) emphasizes routine vaccination combined with mass campaigns in low-coverage areas as key to reducing global measles deaths (WHO Measles Fact Sheet).
Addressing Vaccine Hesitancy
Vaccine hesitancy, often fueled by misinformation about vaccine safety, is a significant barrier. Strategies to address it include:
- Understanding Concerns: Engage with communities to understand reasons for hesitancy, such as distrust in institutions or misinformation about autism risks.
- Evidence-Based Communication: Use clear, empathetic messaging to counter myths, supported by data from credible sources like the CDC and WHO.
- Building Trust: Foster transparency through consistent, community-focused outreach and partnerships with local leaders.
Case Study: Texas Outbreak
Details of the Texas Outbreak
The Texas outbreak, starting in late January 2025, has been a focal point of the U.S. resurgence:
- Case Count: 753 confirmed cases, primarily in West Texas, with Lamar County identified as a key transmission area.
- Hospitalizations: 98 patients hospitalized, reflecting the disease’s severity.
- Fatalities: Two school-aged children, both unvaccinated, died without known underlying conditions.
- Link to Mexico: The outbreak has connections to cases in Chihuahua, Mexico, highlighting cross-border transmission risks.
Lessons Learned
- Early Detection: Rapid identification of cases through surveillance is critical to initiating timely responses.
- Targeted Vaccination: Focused campaigns in under-vaccinated communities can significantly reduce transmission.
- Cross-Border Collaboration: International cooperation is essential to manage imported cases and prevent further spread.
The Texas Department of State Health Services provides updates on the outbreak (Texas DSHS Measles Outbreak).
Global Perspective
Measles Outbreaks Worldwide
The 2025 resurgence is not limited to the U.S. The WHO Region of the Americas reported an 11-fold increase in measles cases compared to 2024, with 2,318 cases across six countries, including 1,069 in Canada and cases in Brazil. Globally, over 22 million children missed their first MMR dose in 2023, contributing to the rise in cases.
Importance of Global Vaccination Efforts
Measles is a global disease, and imported cases pose a constant threat. Strengthening vaccination in low-income countries with weak health infrastructures is critical. The WHO’s Measles and Rubella Strategic Framework (2021–2030) aims to address the estimated 9.7 million cases and 140,000 deaths worldwide, emphasizing routine immunization and rapid response campaigns.
Conclusion
The 2025 measles resurgence serves as a stark reminder of the importance of vaccination and robust infection control. By addressing declining vaccination rates, implementing strict healthcare protocols, and fostering global cooperation, public health officials and infection prevention teams can mitigate the spread of measles. The Texas outbreak underscores the need for rapid, targeted responses in under-vaccinated communities. Together, we can restore FAQ Section
Q1: What are the symptoms of measles?
A1: Measles typically presents with fever, cough, runny nose, red eyes, and a characteristic rash that starts on the face and spreads to the rest of the body.
Q2: How effective is the MMR vaccine?
A2: The MMR vaccine is highly effective, with two doses providing 97% protection against measles.
Q3: Who is most at risk from measles?
A3: Unvaccinated children, infants under 12 months, pregnant women, and immunocompromised individuals are most at risk.
Q4: What should I do if I suspect I have measles?
A4: Contact your healthcare provider immediately. Inform them of your symptoms before visiting to prevent spreading the disease to others.